eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
News Capsules

   Drug Updates

   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



Tussionex Safety

Responding to reports of life-threatening adverse events, including fatal respiratory depression, the Food and Drug Administration is highlighting how to safely use Tussionex Pennkinetic Extended-Release Suspension. Most important are these instructions:

  • Don't give Tussionex to children younger than age 6.
  • Stress to patients that Tussionex can't be taken more than once every 12 hours.
  • Teach patients how to measure the correct dose, and make sure they use a calibrated measuring device.
   A long-acting antitussive–antihistamine, each teaspoon (5 ml) of Tussionex contains hydrocodone polistirex (equivalent to 10 mg of hydrocodone bitartrate) and chlorpheniramine polistirex (equivalent to 8 mg of chlorpheniramine maleate). Tussionex is indicated for relief of cough and upper respiratory symptoms from allergy or cold in adults and children age 6 and older. Each dose provides up to 12 hours of cough relief.


     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins